Myriad is planning to launch its first AI-driven prostate cancer clinical test later this year.

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming ... to confer a terminal prognosis, with a median survival of 12 months from ...

Tests to diagnose prostate cancer may include a computerized tomography (CT) scan, ultrasound, magnetic resonance imaging (MRI), or prostate-specific membrane antigen positron emission tomography scan ...

Lupron is a drug doctors prescribe to treat prostate cancer. It works by reducing testosterone levels in the body, slowing cancer growth. Lupron is the brand name for leuprolide acetate.

Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A ...

From conditions to treatments to surgical devices and more, we've put everything you need to know about urology in one convenient place.